Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03148665 · ClinicalTrials.gov registry record
Saliva-based Detection of CD44
A clinical trial of Squamous Cell Carcinoma of the Head and Neck and Oral Cavity Squamous Cell Carcinoma, sponsored by Joseph Califano.
- Completed
- Registry status
- 85
- Enrollment target
- 4
- Study locations
NCT03148665 is a study of Squamous Cell Carcinoma of the Head and Neck and Oral Cavity Squamous Cell Carcinoma that has completed, run by Joseph Califano. The registered enrollment target is 85 participants, below the 143-participant average among 29 other Squamous Cell Carcinoma of the Head and Neck trials with a reported enrollment target (41% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT03148665, a study of Squamous Cell Carcinoma of the Head and Neck and Oral Cavity Squamous Cell Carcinoma, has completed, sponsored by Joseph Califano.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to test the ability of OncAlert™ to screen for cancer and the reappearance of cancer. OncAlert™ was developed by Vigilant Biosciences, a collaborator in this research study. OncAlert™ is an oral rinse which is spit into a cup and sent to a laboratory for analysis. OncAlert™ is considered experimental by the FDA because it is not approved for the screening of cancer.
Conditions Studied
Interventions
- DEVICE OncAlert
Study Locations (4)
Maryland
- Greater Baltimore Medical Center - Baltimore
- Johns Hopkins School of Medicine - Baltimore
California
- UCSD Moores Cancer Center - La Jolla
New York
- New York University College of Dentistry - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2017-04-14 |
| Est. Completion | 2022-05-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03148665
The ClinicalTrials.gov registry entry for NCT03148665 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 143-participant average among 29 other Squamous Cell Carcinoma of the Head and Neck trials with a reported enrollment target (41% lower). The listed sponsor is Joseph Califano, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Squamous Cell Carcinoma of the Head and Neck appearing as the primary indexed condition, and to 1 intervention - of which OncAlert is the first listed.
NCT03148665 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Maryland, California, New York.
Frequently Asked Questions
What is clinical trial NCT03148665 about?
NCT03148665 is a clinical study titled "Saliva-based Detection of CD44". The purpose of this study is to test the ability of OncAlert™ to screen for cancer and the reappearance of cancer. OncAlert™ was developed by Vigilant Biosciences, a collaborator in this research study. OncAlert™ is an oral rinse which is spit into a cup and sent to a laboratory for analysis. OncAle...
What is the current status of trial NCT03148665?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2017-04-14. Estimated completion is 2022-05-03.
What conditions does trial NCT03148665 study?
This clinical trial studies the following conditions: Squamous Cell Carcinoma of the Head and Neck, Oral Cavity Squamous Cell Carcinoma, Oropharynx Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oropharynx.
What interventions are being tested in trial NCT03148665?
The interventions under investigation include: OncAlert (DEVICE).
Who is sponsoring clinical trial NCT03148665?
This trial is sponsored by Joseph Califano, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03148665 being conducted?
This trial has 4 study locations across California, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Squamous Cell Carcinoma of the Head and Neck
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
RECRUITING · Phase 2
-
Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer
RECRUITING · Phase 2
-
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
RECRUITING · Phase 1
-
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
RECRUITING · Phase 1
-
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RECRUITING · Phase 1
Explore more on PlainTrial
Squamous Cell Carcinoma of the Head and Neck
All registered trials for this condition
Oral Cavity Squamous Cell Carcinoma
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.